Corporate Profile
iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias.

We have created a unique platform, ZIO by iRhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.
IRTC (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 0.82 (1.32%)
Data as of 01/19/18 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: IRTC.O.  Currently trading at $62.75 with a 52 week high of $63.51 and a 52 week low of $28.70.
Recent News
12/21/17iRhythm Technologies to Present at the J.P. Morgan 36th Annual Healthcare ConferencePrinter Friendly Version
11/01/17iRhythm Technologies Announces Third Quarter 2017 Financial Results and Raises Guidance for Full Year 2017Printer Friendly Version
10/18/17iRhythm Technologies to Report Third Quarter 2017 Financial Results on November 1, 2017Printer Friendly Version
Upcoming Events
There are currently no events scheduled.